Similar: From an fda point of view, NuvaRing has similar risks as other hormonal methods. Theoretically, however, the risk of venous thromboembolism and stroke should be much lower as there is no first pass effect in the liver.
Answered 6/30/2014
5.7k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question